Drug Approval | August 31, 2025
FDA suspends Valneva’s license of chikungunya vaccine IXCHIQ in US
The sudden subsequent decision to suspend IXCHIQ is based on updated VAERS data
The sudden subsequent decision to suspend IXCHIQ is based on updated VAERS data
_256_384.jpg)
Marksans Pharma gets USFDA nod for acid reflux drug
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
Merck KGaA, Darmstadt, Germany announced the presentation of new oncology data across more than 12 tumor types at ASCO 2025
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
Findings likely to generate hypotheses about potential new uses of drugs
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
Approval is based on positive data from the Phase 3 ECHELON-3 trial
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
